Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the ClinicLeslie A Parsels, Qiang Zhang, David Karnak, et al.
Neoplasia (New York, N.Y.)|November 21, 2015
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination RepairTasneem Kausar, Jason S Schreiber, David Karnak, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibitionVenkatasubbaiah A Venkatesha, Leslie A Parsels, Joshua D Parsels, et al.
Translational Oncology|March 10, 2015
Targeting mcl-1 for radiosensitization of pancreatic cancersDongping Wei, Qiang Zhang, Jason S Schreiber, et al.
Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
Molecular Cancer Research : MCR|May 28, 2021
Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent MannerKailiang Zhao, Qiang Zhang, Sheryl A Flanagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2014
Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancerDavid Karnak, Carl G Engelke, Leslie A Parsels, et al.
Molecular Cancer Research : MCR|November 15, 2017
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP InhibitorsLeslie A Parsels, David Karnak, Joshua D Parsels, et al.
Molecular Cancer Therapeutics|January 14, 2009
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cellsLeslie A Parsels, Meredith A Morgan, Daria M Tanska, et al.
Pageof 4